Fjarde Ap-fonden’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.55M Sell
86,743
-30,600
-26% -$2.01M 0.03% 394
2026
Q1
$8.35M Buy
117,343
+30,388
+35% +$2.4M 0.05% 318
2025
Q4
$7.13M Sell
86,955
-1,800
-2% -$140K 0.06% 278
2025
Q3
$6.67M Sell
88,755
-9,100
-9% -$679K 0.06% 278
2025
Q2
$7.25M Buy
97,855
+38,200
+64% +$2.66M 0.07% 268
2025
Q1
$4.82M Sell
59,655
-12,500
-17% -$1.07M 0.06% 307
2024
Q4
$5.64M Sell
72,155
-9,800
-12% -$833K 0.06% 316
2024
Q3
$7.69M Buy
+81,955
New +$6.88M 0.08% 246
2024
Q1
$9.3M Buy
102,255
+17,700
+21% +$1.47M 0.1% 212
2023
Q4
$6.54M Buy
84,555
+19,200
+29% +$1.34M 0.08% 254
2023
Q3
$4.45M Sell
65,355
-2,400
-4% -$175K 0.06% 337
2023
Q2
$5.5M Buy
67,755
+13,300
+24% +$1.06M 0.07% 300
2023
Q1
$4.47M Buy
+54,455
New +$3.89M 0.06% 337

Other funds holding GEHC

Fjarde Ap-fonden's GEHC Position: Q2 2026 in Review

Fjarde Ap-fonden reduced its GE HealthCare (GEHC) stake by 26% in Q2 2026, selling an estimated $2.01M and leaving 86,743 shares worth $5.55M. The position accounts for 0.03% of the portfolio, ranked #394.

Fjarde Ap-fonden first reported a position in GEHC in Q1 2023 and has held it in 13 quarters since. The position peaked at $9.3M in Q1 2024. 1,223 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Fjarde Ap-fonden held 86,743 shares of GE HealthCare worth $5.55M as of Q2 2026.
  • Fjarde Ap-fonden sold 30,600 GE HealthCare shares in Q2 2026, an estimated $2.01M.
  • GE HealthCare made up 0.03% of Fjarde Ap-fonden's portfolio in Q2 2026, its #394 holding.
  • Fjarde Ap-fonden first reported a position in GE HealthCare in Q1 2023 and has held it in 13 quarters since.
  • Fjarde Ap-fonden's GE HealthCare position peaked at $9.3M in Q1 2024.
  • 1,223 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Fjarde Ap-fonden's 13F filing for Q2 2026, filed 29 Jul 2026.